Searchable abstracts of presentations at key conferences in endocrinology

ea0011p353 | Diabetes, metabolism and cardiovascular | ECE2006

The metabolic syndrome and insulin resistance in polycystic ovary syndrome – study over 40 patients

Neamtu C , Gherlan I , Boanta C , Caragheorgheopol A , Dumitrache C

Insulin resistance is possibly playing an underlying pathogenic role in the polycystic ovary syndrome (PCOS) and although is not a part of its definition, it appears in 50-90% of PCOS women. Polycystic ovary syndrome is also frequently associated with obesity; women suffering of PCOS seem to be at a great risk of developing a metabolic syndrome.Objectives: The aim of our study was to determine the prevalence of the metabolic syndrome in a population of 4...

ea0022p146 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Acromegaly and endothelial dysfunction: is there any relation between?

Dragomir Adina Simona , Badiu Corin , Popescu Irina , Ghemigean Adina , Boanta Catalina , Dumitrache Constantin

Objectives: Endothelial dysfunction has been described as a predictor of cardiovascular complications. Most important cause for early mortality in acromegaly is cardiovascular involvement, cut-off nadir GH <2.5 ng/ml predicting longer survival The aim of our study was to determine the correlations between endothelial dysfunction and GH oversecretion, associated or not with other cardiovascular risk factors.Design and method: Cross-sectional study inc...

ea0022p691 | Obesity | ECE2010

Predictive factors for a good response to antidepressant pharmacotherapy in patients with metabolic syndrome

Vija Lavinia , Oros Sabina , Dragomir Adina , Iconaru Laura , Gudovan Emilia , Boanta Catalina , Dumitrache Constantin

Objectives: Metabolic syndrome, especially obesity and diabetes are associated and responsible for a depressive psychological status. Meanwhile, antidepressors are responsible for metabolic disturbances, such as insulin resistance. The study aims to determine predictive factors of response to antidepressant pharmacotherapy in patients with metabolic syndrome.Materials and methods: A retrospective study conducted in Institute Parhon’s Department for ...

ea0090ep1035 | Thyroid | ECE2023

Graves’ Disease Hiding Metastatic Papillary Thyroid Carcinoma - case report-

Musat Madalina , Septar AIlin , Boanta Roxana , Goldstein Andrei , Terzea Dana , Ioachim Dumitru , Schipor Sorina , Muresan Andrei , Niculescu Dan , Elian Viviana

The coexistence of Graves disease (GD) and thyroid carcinoma used to be considered uncommon, but association between the two is being progressively acknowledged. Case report: We present the case of a 69-year-old woman with a 10 year history of GD who was referred to our clinic for fatigue, sweating, palpable cervical mass and weight loss. She was treated only in the previous 5 months with block and replace therapy. Laboratory workup at admission showed s...